Jane Gross
Director/Miembro de la Junta en ATYR PHARMA, INC. .
Fortuna: 9 570 $ al 30/04/2024
Perfil
Dr. Jane A.
Gross is an Independent Director at BriaCell Therapeutics Corp., an Independent Director at aTyr Pharma, Inc. and an Independent Director at BriaPro Therapeutics Corp.
She is on the Board of Directors at BriaCell Therapeutics Corp., aTyr Pharma, Inc., Washington Biotechnology & Biomedical Association and BriaPro Therapeutics Corp.
Dr. Gross was previously employed as a Chief Scientific Officer & Senior Vice President by Aptevo Therapeutics, Inc., a VP-Applied Research & Non-Clinical Development by Emergent BioSolutions, Inc., and a Vice President-Immunology Research by ZymoGenetics, Inc. She received her doctorate degree from the University of California, Berkeley.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ATYR PHARMA, INC.
0.01% | 01/03/2024 | 6 000 ( 0.01% ) | 9 570 $ | 30/04/2024 |
| 20/12/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Jane Gross
| Empresas | Cargo | Inicio |
|---|---|---|
| ATYR PHARMA, INC. | Director/Miembro de la Junta | 28/06/2019 |
| BRIACELL THERAPEUTICS CORP. | Director/Miembro de la Junta | 01/11/2021 |
| Washington Biotechnology & Biomedical Association | Director/Miembro de la Junta | - |
BriaPro Therapeutics Corp.
 BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Jane Gross.
| Empresas | Cargo | Fin |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Director Técnico/Científico/I+D | 14/09/2021 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/08/2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/06/2010 |
Formación de Jane Gross.
| University of California, Berkeley | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Empresas privadas | 3 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Jane Gross